Loading clinical trials...
Loading clinical trials...
An Open-Label, Multicenter, Randomized, Phase II Study of Topotecan/Paclitaxel vs Etoposide/Cisplatin as First-Line Therapy for Patients With Extensive Disease Small Cell Lung Cancer
Conditions
Interventions
filgrastim
cisplatin
+3 more
Start Date
October 1, 1999
Primary Completion Date
June 1, 2001
Completion Date
June 1, 2001
Last Updated
January 15, 2014
NCT05198830
NCT05692635
NCT06305754
NCT07336732
NCT07190248
NCT06498635
Lead Sponsor
Case Comprehensive Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions